|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Acusphere Inc., of Watertown, Mass., entered an agreement to lease commercial manufacturing space in Tewksbury, Mass. The specialty pharmaceutical company plans to develop the facility to meet its anticipated initial commercial production needs for AI-700, an ultrasound contrast agent in Phase III trials for the detection of coronary heart disease.
o ArQule Inc., of Woburn, Mass., said a Phase I study of ARQ 501 as monotherapy continues to enroll patients. The drug has been well tolerated, the company said, and dose escalation will continue to identify the maximum tolerated dose. In the latter part of the year, a new Phase Ib/II study combining ARQ 501 with ...